tiprankstipranks
Trending News
More News >
Corcept Therapeutics (DE:HTD)
:HTD
Germany Market

Corcept Therapeutics (HTD) Ratios

Compare
2 Followers

Corcept Therapeutics Ratios

DE:HTD's free cash flow for Q1 2025 was $0.98. For the 2025 fiscal year, DE:HTD's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.07 4.39 6.11 55.21 49.67
Quick Ratio
2.96 4.31 5.90 52.61 47.67
Cash Ratio
0.63 1.30 5.35 48.61 45.19
Solvency Ratio
0.82 0.93 1.28 2.41 2.24
Operating Cash Flow Ratio
1.25 1.22 1.47 24.30 14.40
Short-Term Operating Cash Flow Coverage
182.36 0.00 105.27 319.19 0.00
Net Current Asset Value
$ 275.33M$ 343.82M$ 417.12M$ 333.44M$ 475.85M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
<0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.24 1.23 1.16 1.13 1.09
Debt Service Coverage Ratio
88.77 0.00 20.82 212.90 0.00
Interest Coverage Ratio
0.00 0.00 31.67 0.00 0.00
Debt to Market Cap
<0.01 0.00 <0.01 <0.01 0.00
Interest Debt Per Share
0.07 <0.01 0.04 <0.01 0.02
Net Debt to EBITDA
-0.75 -1.25 -3.87 -2.69 -3.64
Profitability Margins
Gross Profit Margin
98.43%98.66%98.66%98.56%98.42%
EBIT Margin
17.53%22.24%28.91%34.16%36.23%
EBITDA Margin
16.24%22.46%28.03%34.01%36.86%
Operating Profit Margin
16.17%22.24%28.03%34.01%36.23%
Pretax Profit Margin
19.86%25.82%28.91%34.16%37.19%
Net Profit Margin
19.38%22.00%25.24%30.74%29.96%
Continuous Operations Profit Margin
19.51%22.00%25.24%30.74%29.96%
Net Income Per EBT
97.60%85.21%87.29%90.01%80.55%
EBT Per EBIT
122.77%116.10%103.16%100.42%102.65%
Return on Assets (ROA)
15.70%17.08%17.38%26.55%18.54%
Return on Equity (ROE)
20.46%20.95%20.21%29.94%20.26%
Return on Capital Employed (ROCE)
15.76%20.75%22.44%29.86%22.85%
Return on Invested Capital (ROIC)
12.97%17.68%19.50%26.81%18.34%
Return on Tangible Assets
15.70%17.08%17.38%20.99%17.44%
Earnings Yield
1.79%3.16%4.68%4.91%3.51%
Efficiency Ratios
Receivables Turnover
11.09 11.73 12.94 13.25 13.51
Payables Turnover
0.38 0.37 0.45 0.76 0.53
Inventory Turnover
0.75 0.84 0.32 0.29 0.26
Fixed Asset Turnover
89.13 1.53K 351.58 712.02 141.04
Asset Turnover
0.81 0.78 0.69 0.86 0.62
Working Capital Turnover Ratio
2.19 1.25 1.02 0.82 0.86
Cash Conversion Cycle
-428.14 -513.26 370.84 790.73 720.34
Days of Sales Outstanding
32.92 31.12 28.21 27.55 27.02
Days of Inventory Outstanding
487.84 435.34 1.15K 1.24K 1.38K
Days of Payables Outstanding
948.90 979.72 811.74 477.45 690.11
Operating Cycle
520.76 466.46 1.18K 1.27K 1.41K
Cash Flow Ratios
Operating Cash Flow Per Share
1.72 1.23 1.13 1.45 1.32
Free Cash Flow Per Share
1.70 1.23 1.12 1.45 1.31
CapEx Per Share
0.02 <0.01 <0.01 <0.01 0.01
Free Cash Flow to Operating Cash Flow
0.99 1.00 1.00 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
78.84 913.95 291.34 357.98 122.75
Capital Expenditure Coverage Ratio
78.84 913.95 291.34 357.98 122.75
Operating Cash Flow Coverage Ratio
26.25 841.32 105.27 319.19 59.57
Operating Cash Flow to Sales Ratio
0.26 0.26 0.30 0.46 0.43
Free Cash Flow Yield
2.34%3.77%5.53%7.31%4.99%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
55.93 31.69 21.39 20.35 28.48
Price-to-Sales (P/S) Ratio
11.04 6.97 5.40 6.26 8.53
Price-to-Book (P/B) Ratio
10.88 6.64 4.32 6.09 5.77
Price-to-Free Cash Flow (P/FCF) Ratio
42.73 26.51 18.09 13.68 20.03
Price-to-Operating Cash Flow Ratio
41.41 26.48 18.03 13.64 19.87
Price-to-Earnings Growth (PEG) Ratio
-9.44 4.30 -10.37 3.74 2.34
Price-to-Fair Value
10.88 6.64 4.32 6.09 5.77
Enterprise Value Multiple
67.25 29.80 15.39 15.70 19.51
Enterprise Value
7.49B 3.23B 1.73B 1.95B 2.54B
EV to EBITDA
67.25 29.80 15.39 15.70 19.51
EV to Sales
10.92 6.69 4.31 5.34 7.19
EV to Free Cash Flow
42.26 25.44 14.46 11.67 16.88
EV to Operating Cash Flow
41.72 25.41 14.41 11.64 16.75
Tangible Book Value Per Share
6.56 4.89 4.70 3.25 4.53
Shareholders’ Equity Per Share
6.56 4.89 4.70 3.25 4.53
Tax and Other Ratios
Effective Tax Rate
0.18 0.15 0.13 0.10 0.19
Revenue Per Share
6.58 4.66 3.76 3.16 3.07
Net Income Per Share
1.28 1.02 0.95 0.97 0.92
Tax Burden
0.98 0.85 0.87 0.90 0.81
Interest Burden
1.13 1.16 1.00 1.00 1.03
Research & Development to Revenue
0.36 0.38 0.33 0.31 0.32
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.10 0.10 0.11 0.12 0.09
Income Quality
1.35 1.20 1.19 1.49 1.43
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis